Discover Other news:
 

UK Regulatory Affairs Services

17 November 2020

News

AUTHOR: Antony Appleyard



From the 1st January 2021 the UK will operate a stand-alone regulatory system for medicines and healthcare products. In recent months the UK government and MHRA have been publishing and updating the details of the Post-Brexit regulatory system.
Diamond Pharma Services provide a comprehensive range of UK regulatory affairs services to help companies to ensure that their UK regulatory commitments remain in compliance, and that all opportunities are maximised at this time of change.
For more details about the UK regulatory affairs services offered please visit our dedicated service web page.

Alternatively, contact James Wisely for more information on +44 (0)7811 198169 or via Email at JWisely@diamondpharmaservices.com.

17 November 2020

News

AUTHOR: Antony Appleyard